CKD
AstraZeneca shares results from ZENITH-CKD phase 2b trial for chronic kidney disease and proteinuria treatment
November 6, 2023Research and Development AstraZeneca, CKD, Nephrology, kidney disease, proteinuria
AstraZeneca has announced results from the ZENITH-CKD phase 2b clinical trial for the combination of zibotentan with dapagliflozin for the …
CHMP gives positive opinion recommending authorisation to GSK’s CKD drug
June 26, 2023Medical Communications CKD, EMA, Nephrology
Global biopharmaceutical company GSK has announced that the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) …
Astellas receives positive CHMP opinion for symptomatic anaemia drug
June 28, 2021Sales and Marketing Astellas, CKD, anaemia
Astellas and FibroGen have announced that the Committee for Medicinal Products for Human Use (CHMP) of the EMA has adopted …
Evotec and Chinook to partner on new kidney disease treatments
March 1, 2021Sales and Marketing CKD, Chinook, Evotec, chronic kidney disease, kidney disease
Evotec and Chinook Therapeutics have agreed a deal to discover and develop new therapies for patients with chronic kidney diseases …
Keryx Biopharmaceuticals announces positive Phase III study results for anaemia treatment
March 30, 2016Research and Development CKD, anaemia, chronic kidney disease, clinical trial, dialysis, keryx, keryx biopharmaceuticals, kidney, phase 3, phase III
Keryx Biopharmaceuticals (NASDAQ: KERX) has announced positive top-line results for its Phase III study of ferric citrate for the treatment …
AstraZeneca signs $350m kidney deal
August 1, 2013Sales and Marketing AstraZeneca, CKD, fibrogen, kidney
AstraZeneca has signed a deal with private biotech company FibroGen to develop a novel compound aimed at treating anaemia associated …
Latest content
Five Facts about cardiovascular disease
